group_id,Component_36,apul,peve,ptua,type,avg_identity,query,accession,id,reviewed,protein_name,organism,pident,length,evalue,bitscore,title,go_ids,go_bp,go_cc,go_mf,goslim_ids,goslim_names
OG_07144,0.4610968365054212,FUN_032474-T1,Peve_00036450,Pocillopora_meandrina_HIv1___RNAseq.g24244.t1,three_way,56.147333333333336,,,,,,,,,,,,,,,,,
OG_05071,0.4293612435050484,FUN_023293-T1,Peve_00003652,Pocillopora_meandrina_HIv1___RNAseq.g23035.t1,three_way,68.382,,,,,,,,,,,,,,,,,
OG_00948,0.4183418807839026,FUN_004307-T1,Peve_00033930,Pocillopora_meandrina_HIv1___RNAseq.g11779.t1,three_way,63.568666666666665,FUN_004307-T1,O96952,,,,,51.0,102.0,1.3e-23,111.3,sp|O96952|THIO_GEOCY Thioredoxin OS=Geodia cydonium OX=6047 GN=THIO PE=3 SV=1,,,,,,
OG_00531,0.4177919959588643,FUN_001545-T1,Peve_00033291,Pocillopora_meandrina_HIv1___RNAseq.g15386.t1,three_way,49.809666666666665,,,,,,,,,,,,,,,,,
OG_06154,0.3859796641960905,FUN_027987-T1,Peve_00023127,Pocillopora_meandrina_HIv1___RNAseq.g14022.t1,three_way,64.95433333333334,,,,,,,,,,,,,,,,,
OG_09178,0.3813985153732567,FUN_039858-T1,Peve_00020641,Pocillopora_meandrina_HIv1___RNAseq.g7287.t1a,three_way,34.05316666666667,,,,,,,,,,,,,,,,,
OG_03269,0.3700715759452279,FUN_013138-T1,Peve_00042391,Pocillopora_meandrina_HIv1___TS.g15900.t1,three_way,81.306,FUN_013138-T1,Q7RTY7,OVCH1_HUMAN,,Ovochymase-1 (EC 3.4.21.-),Homo sapiens (Human),39.4,251.0,5.999999999999999e-44,179.5,sp|Q7RTY7|OVCH1_HUMAN Ovochymase-1 OS=Homo sapiens OX=9606 GN=OVCH1 PE=1 SV=3,GO:0004252; GO:0005576; GO:0006508; GO:0046872,proteolysis [GO:0006508],extracellular region [GO:0005576],metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252],GO:0003824; GO:0005576; GO:0016787; GO:0140096,"catalytic activity; extracellular region; hydrolase activity; catalytic activity, acting on a protein"
OG_02408,0.3684237461512571,FUN_009228-T2,Peve_00014803,Pocillopora_meandrina_HIv1___RNAseq.g6343.t1,three_way,63.64683333333333,FUN_009228-T2,Q24JV9,,,,,50.0,106.0,4.5000000000000003e-23,113.6,sp|Q24JV9|L3BPA_DANRE Galectin-3-binding protein A OS=Danio rerio OX=7955 GN=lgals3bpa PE=2 SV=1,,,,,,
OG_00643,0.338435375044091,FUN_001887-T1,Peve_00030489,Pocillopora_meandrina_HIv1___RNAseq.g29129.t1,three_way,64.38266666666667,FUN_001887-T1,Q7RTY7,OVCH1_HUMAN,,Ovochymase-1 (EC 3.4.21.-),Homo sapiens (Human),40.6,286.0,1.8000000000000002e-44,181.8,sp|Q7RTY7|OVCH1_HUMAN Ovochymase-1 OS=Homo sapiens OX=9606 GN=OVCH1 PE=1 SV=3,GO:0004252; GO:0005576; GO:0006508; GO:0046872,proteolysis [GO:0006508],extracellular region [GO:0005576],metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252],GO:0003824; GO:0005576; GO:0016787; GO:0140096,"catalytic activity; extracellular region; hydrolase activity; catalytic activity, acting on a protein"
OG_02728,0.3161471240674606,FUN_011252-T1,Peve_00024318,Pocillopora_meandrina_HIv1___RNAseq.g11307.t1,three_way,52.192,,,,,,,,,,,,,,,,,
OG_06086,0.3144481941188108,FUN_027084-T1,Peve_00013218,Pocillopora_meandrina_HIv1___RNAseq.g2808.t1,three_way,82.44433333333333,FUN_027084-T1,Q3ZBR6,,,,,77.6,49.0,1.5e-13,77.0,sp|Q3ZBR6|SEM1_BOVIN 26S proteasome complex subunit SEM1 OS=Bos taurus OX=9913 GN=SEM1 PE=3 SV=1,,,,,,
OG_05654,0.2935976802846711,FUN_025403-T1,Peve_00026689,Pocillopora_meandrina_HIv1___RNAseq.g13308.t1,three_way,71.69633333333334,FUN_025403-T1,Q7SXN5,DNM1L_DANRE,,Dynamin-1-like protein (EC 3.6.5.5),Danio rerio (Zebrafish) (Brachydanio rerio),21.1,701.0,1.2e-07,60.1,sp|Q7SXN5|DNM1L_DANRE Dynamin-1-like protein OS=Danio rerio OX=7955 GN=dnm1l PE=2 SV=1,GO:0000266; GO:0003924; GO:0005525; GO:0005737; GO:0005739; GO:0005741; GO:0005777; GO:0005794; GO:0005829; GO:0005874; GO:0005905; GO:0006897; GO:0008017; GO:0008289; GO:0016020; GO:0016559; GO:0030672; GO:0042803; GO:0043653; GO:0048312; GO:0048511; GO:0051259,endocytosis [GO:0006897]; intracellular distribution of mitochondria [GO:0048312]; mitochondrial fission [GO:0000266]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; peroxisome fission [GO:0016559]; protein complex oligomerization [GO:0051259]; rhythmic process [GO:0048511],clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; microtubule [GO:0005874]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; peroxisome [GO:0005777]; synaptic vesicle membrane [GO:0030672],GTP binding [GO:0005525]; GTPase activity [GO:0003924]; lipid binding [GO:0008289]; microtubule binding [GO:0008017]; protein homodimerization activity [GO:0042803],GO:0003824; GO:0003924; GO:0005739; GO:0005777; GO:0005794; GO:0005829; GO:0007005; GO:0008092; GO:0008289; GO:0016192; GO:0016787; GO:0043226; GO:0065003,catalytic activity; GTPase activity; mitochondrion; peroxisome; Golgi apparatus; cytosol; mitochondrion organization; cytoskeletal protein binding; lipid binding; vesicle-mediated transport; hydrolase activity; organelle; protein-containing complex assembly
OG_00246,0.2933995560939854,FUN_001009-T1,Peve_00041033,Pocillopora_meandrina_HIv1___TS.g6384.t1,three_way,55.748666666666665,FUN_001009-T1,P97739,,,,,36.8,749.0,9.2e-134,479.2,sp|P97739|ECE1_CAVPO Endothelin-converting enzyme 1 OS=Cavia porcellus OX=10141 GN=ECE1 PE=2 SV=1,,,,,,
OG_02927,0.2876463830408071,FUN_012020-T1,Peve_00030377,Pocillopora_meandrina_HIv1___RNAseq.g24050.t1,three_way,58.77833333333333,FUN_012020-T1,Q5UAW9,GP157_HUMAN,,G-protein coupled receptor 157,Homo sapiens (Human),34.6,289.0,1.7e-39,164.9,sp|Q5UAW9|GP157_HUMAN G-protein coupled receptor 157 OS=Homo sapiens OX=9606 GN=GPR157 PE=1 SV=2,GO:0004930; GO:0005886; GO:0007166; GO:0007189; GO:0007200; GO:0048512; GO:0060019; GO:0060170,adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; circadian behavior [GO:0048512]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; radial glial cell differentiation [GO:0060019],ciliary membrane [GO:0060170]; plasma membrane [GO:0005886],G protein-coupled receptor activity [GO:0004930],GO:0005886; GO:0030154; GO:0060089,plasma membrane; cell differentiation; molecular transducer activity
OG_07229,0.2862292315790041,FUN_032885-T1,Peve_00001722,Pocillopora_meandrina_HIv1___RNAseq.g29858.t1,three_way,52.5095,,,,,,,,,,,,,,,,,
OG_02341,0.2850461734050775,FUN_008940-T1,Peve_00007194,Pocillopora_meandrina_HIv1___TS.g30103.t1,three_way,71.29533333333333,FUN_008940-T1,P31422,GRM3_RAT,,Metabotropic glutamate receptor 3 (mGluR3),Rattus norvegicus (Rat),41.0,808.0,1.2999999999999998e-173,611.7,sp|P31422|GRM3_RAT Metabotropic glutamate receptor 3 OS=Rattus norvegicus OX=10116 GN=Grm3 PE=1 SV=1,GO:0001641; GO:0005246; GO:0005886; GO:0007216; GO:0010467; GO:0014069; GO:0019233; GO:0030424; GO:0033554; GO:0042734; GO:0043005; GO:0043197; GO:0045211; GO:0050804; GO:0051966; GO:0097110; GO:0097449; GO:0098978; GO:0099170,"cellular response to stress [GO:0033554]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; gene expression [GO:0010467]; modulation of chemical synaptic transmission [GO:0050804]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; regulation of synaptic transmission, glutamatergic [GO:0051966]; sensory perception of pain [GO:0019233]",astrocyte projection [GO:0097449]; axon [GO:0030424]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734],calcium channel regulator activity [GO:0005246]; group II metabotropic glutamate receptor activity [GO:0001641]; scaffold protein binding [GO:0097110],GO:0005886; GO:0043226; GO:0050877; GO:0060089; GO:0098772,plasma membrane; organelle; nervous system process; molecular transducer activity; molecular function regulator activity
OG_09443,0.2846795545466455,FUN_041432-T2,Peve_00027845,Pocillopora_meandrina_HIv1___RNAseq.g15740.t1,three_way,86.71633333333334,FUN_041432-T2,Q90837,,,,,41.4,459.0,1.8000000000000002e-81,304.7,sp|Q90837|ERG_CHICK Transcriptional regulator Erg OS=Gallus gallus OX=9031 GN=ERG PE=2 SV=1,,,,,,
OG_02998,0.2828835123195995,FUN_012177-T1,Peve_00040996,Pocillopora_meandrina_HIv1___RNAseq.g23859.t1,three_way,91.90766666666669,FUN_012177-T1,P18654,KS6A3_MOUSE,,Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2),Mus musculus (Mouse),67.4,742.0,1e-291,1003.8,sp|P18654|KS6A3_MOUSE Ribosomal protein S6 kinase alpha-3 OS=Mus musculus OX=10090 GN=Rps6ka3 PE=1 SV=2,GO:0000287; GO:0002224; GO:0004674; GO:0005524; GO:0005654; GO:0005730; GO:0005829; GO:0019901; GO:0032496; GO:0035556; GO:0043066; GO:0045944; GO:0106310,intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; positive regulation of transcription by RNA polymerase II [GO:0045944]; response to lipopolysaccharide [GO:0032496]; toll-like receptor signaling pathway [GO:0002224],cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654],ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0002376; GO:0003824; GO:0005654; GO:0005730; GO:0005829; GO:0006355; GO:0016740; GO:0043226; GO:0140096,"immune system process; catalytic activity; nucleoplasm; nucleolus; cytosol; regulation of DNA-templated transcription; transferase activity; organelle; catalytic activity, acting on a protein"
OG_02090,0.2815658749249158,FUN_008328-T1,Peve_00040489,Pocillopora_meandrina_HIv1___TS.g24166.t1,three_way,48.269666666666666,FUN_008328-T1,B3EWY9,,,,,39.3,990.0,2.1999999999999998e-166,589.3,sp|B3EWY9|MLP_ACRMI Mucin-like protein (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1,,,,,,
OG_09472,0.2810173573104069,FUN_041498-T1,Peve_00007700,Pocillopora_meandrina_HIv1___TS.g10682.t1,three_way,80.48866666666666,FUN_041498-T1,Q6Q2B2,,,,,39.5,253.0,1.1e-33,145.6,sp|Q6Q2B2|MBN2A_TAKRU Muscleblind-like protein 2a OS=Takifugu rubripes OX=31033 GN=mbnl2a PE=2 SV=1,,,,,,
OG_05826,0.2806904804263412,FUN_025843-T1,Peve_00028316,Pocillopora_meandrina_HIv1___RNAseq.g10339.t1,three_way,66.52566666666667,,,,,,,,,,,,,,,,,
OG_02484,0.2806517649565039,FUN_009778-T1,Peve_00026798,Pocillopora_meandrina_HIv1___RNAseq.g24554.t1,three_way,71.61233333333334,FUN_009778-T1,P41216,,,,,47.2,642.0,8e-176,618.6,sp|P41216|ACSL1_MOUSE Long-chain-fatty-acid--CoA ligase 1 OS=Mus musculus OX=10090 GN=Acsl1 PE=1 SV=2,,,,,,
OG_04538,0.2793011963624914,FUN_022094-T1,Peve_00038682,Pocillopora_meandrina_HIv1___RNAseq.g4121.t1,three_way,74.00383333333333,FUN_022094-T1,Q5R5C1,UROM_PONAB,,"Uromodulin [Cleaved into: Uromodulin, secreted form]",Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),25.9,336.0,2.6e-20,101.7,sp|Q5R5C1|UROM_PONAB Uromodulin OS=Pongo abelii OX=9601 GN=UMOD PE=2 SV=1,GO:0000922; GO:0005509; GO:0005576; GO:0005929; GO:0016020; GO:0016323; GO:0016324; GO:0050829; GO:0060170; GO:0098552; GO:0140367,antibacterial innate immune response [GO:0140367]; defense response to Gram-negative bacterium [GO:0050829],apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; extracellular region [GO:0005576]; membrane [GO:0016020]; side of membrane [GO:0098552]; spindle pole [GO:0000922],calcium ion binding [GO:0005509],GO:0002376; GO:0005576; GO:0005929; GO:0043226; GO:0098542,immune system process; extracellular region; cilium; organelle; defense response to other organism
OG_00242,0.2789766886907178,FUN_001005-T1,Peve_00015285,Pocillopora_meandrina_HIv1___TS.g6390.t1,three_way,40.208,,,,,,,,,,,,,,,,,
OG_09120,0.2787761678210114,FUN_039266-T1,Peve_00002772,Pocillopora_meandrina_HIv1___RNAseq.g13577.t1,three_way,76.14266666666667,FUN_039266-T1,P12394,,,,,43.7,462.0,3.8999999999999998e-109,396.7,"sp|P12394|CP17A_CHICK Steroid 17-alpha-hydroxylase/17,20 lyase OS=Gallus gallus OX=9031 GN=CYP17A1 PE=2 SV=1",,,,,,
OG_05478,0.278157488845259,FUN_024472-T1,Peve_00041386,Pocillopora_meandrina_HIv1___RNAseq.g29213.t1,three_way,48.294,,,,,,,,,,,,,,,,,
OG_06663,0.2753657435513618,FUN_031054-T1,Peve_00028185,Pocillopora_meandrina_HIv1___RNAseq.g30322.t1,three_way,84.973,FUN_031054-T1,Q8CIB5,FERM2_MOUSE,,Fermitin family homolog 2 (Kindlin-2) (Pleckstrin homology domain-containing family C member 1),Mus musculus (Mouse),47.4,694.0,4.1000000000000004e-170,599.7,sp|Q8CIB5|FERM2_MOUSE Fermitin family homolog 2 OS=Mus musculus OX=10090 GN=Fermt2 PE=1 SV=1,GO:0001725; GO:0005547; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005912; GO:0005925; GO:0005938; GO:0007160; GO:0007179; GO:0007229; GO:0008360; GO:0009898; GO:0009986; GO:0010718; GO:0016055; GO:0031258; GO:0031674; GO:0033622; GO:0033625; GO:0034334; GO:0034446; GO:0034713; GO:0035025; GO:0043116; GO:0043539; GO:0045599; GO:0045669; GO:0046332; GO:0048041; GO:0051015; GO:0051496; GO:0051894; GO:0051897; GO:0060173; GO:0070374; GO:0072657; GO:0120283; GO:1900026; GO:1900182; GO:1902414; GO:1902462; GO:1903691,"adherens junction maintenance [GO:0034334]; cell-matrix adhesion [GO:0007160]; focal adhesion assembly [GO:0048041]; integrin activation [GO:0033622]; integrin-mediated signaling pathway [GO:0007229]; limb development [GO:0060173]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of vascular permeability [GO:0043116]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of integrin activation [GO:0033625]; positive regulation of mesenchymal stem cell proliferation [GO:1902462]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of Rho protein signal transduction [GO:0035025]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of wound healing, spreading of epidermal cells [GO:1903691]; protein localization to cell junction [GO:1902414]; protein localization to membrane [GO:0072657]; regulation of cell shape [GO:0008360]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179]; Wnt signaling pathway [GO:0016055]",adherens junction [GO:0005912]; cell cortex [GO:0005938]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; I band [GO:0031674]; lamellipodium membrane [GO:0031258]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; stress fiber [GO:0001725],"actin filament binding [GO:0051015]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; protein serine/threonine kinase activator activity [GO:0043539]; protein serine/threonine kinase binding [GO:0120283]; SMAD binding [GO:0046332]; type I transforming growth factor beta receptor binding [GO:0034713]",GO:0003013; GO:0005634; GO:0005654; GO:0005829; GO:0007155; GO:0008092; GO:0008289; GO:0034330; GO:0043226; GO:0048856; GO:0065003; GO:0098772,circulatory system process; nucleus; nucleoplasm; cytosol; cell adhesion; cytoskeletal protein binding; lipid binding; cell junction organization; organelle; anatomical structure development; protein-containing complex assembly; molecular function regulator activity
OG_01486,0.2703109417373188,FUN_006162-T1,Peve_00024180,Pocillopora_meandrina_HIv1___RNAseq.g20422.t1,three_way,46.14,FUN_006162-T1,Q90827,,,,,30.2,129.0,2.5e-09,65.1,sp|Q90827|NEL_CHICK Protein NEL OS=Gallus gallus OX=9031 GN=NEL PE=2 SV=1,,,,,,
OG_03108,0.2660120820972179,FUN_012405-T1,Peve_00002856,Pocillopora_meandrina_HIv1___RNAseq.g9951.t1,three_way,66.98066666666666,,,,,,,,,,,,,,,,,
OG_09625,0.2655850668739421,FUN_041789-T1,Peve_00038532,Pocillopora_meandrina_HIv1___RNAseq.g15770.t1,three_way,64.701,FUN_041789-T1,O15072,ATS3_HUMAN,,A disintegrin and metalloproteinase with thrombospondin motifs 3 (ADAM-TS 3) (ADAM-TS3) (ADAMTS-3) (EC 3.4.24.-) (Procollagen II N-proteinase) (PC II-NP) (Procollagen II amino propeptide-processing enzyme),Homo sapiens (Human),30.6,992.0,5.3e-119,430.6,sp|O15072|ATS3_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 3 OS=Homo sapiens OX=9606 GN=ADAMTS3 PE=1 SV=4,GO:0001701; GO:0004175; GO:0004222; GO:0005576; GO:0005615; GO:0006508; GO:0008201; GO:0008270; GO:0010573; GO:0016485; GO:0030198; GO:0030199; GO:0030574; GO:0031012; GO:0032964; GO:0070062; GO:0097435; GO:1900748,collagen biosynthetic process [GO:0032964]; collagen catabolic process [GO:0030574]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; in utero embryonic development [GO:0001701]; positive regulation of vascular endothelial growth factor signaling pathway [GO:1900748]; protein processing [GO:0016485]; proteolysis [GO:0006508]; supramolecular fiber organization [GO:0097435]; vascular endothelial growth factor production [GO:0010573],extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615],endopeptidase activity [GO:0004175]; heparin binding [GO:0008201]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270],GO:0003824; GO:0005576; GO:0005615; GO:0016787; GO:0030198; GO:0030312; GO:0031012; GO:0043226; GO:0048856; GO:0051604; GO:0140096,"catalytic activity; extracellular region; extracellular space; hydrolase activity; extracellular matrix organization; external encapsulating structure; extracellular matrix; organelle; anatomical structure development; protein maturation; catalytic activity, acting on a protein"
OG_02976,0.2655465057070088,FUN_012142-T1,Peve_00001101,Pocillopora_meandrina_HIv1___RNAseq.g23866.t1,three_way,57.71,,,,,,,,,,,,,,,,,
OG_03910,0.2634613054484074,FUN_015986-T1,Peve_00024004,Pocillopora_meandrina_HIv1___RNAseq.g21398.t1,three_way,64.2585,,,,,,,,,,,,,,,,,
OG_07835,0.2609579437426889,FUN_035161-T1,Peve_00006324,Pocillopora_meandrina_HIv1___RNAseq.11026_t,three_way,61.05166666666667,FUN_035161-T1,Q923Y6,,,,,26.7,330.0,9.8e-13,75.9,sp|Q923Y6|TAAR9_RAT Trace amine-associated receptor 9 OS=Rattus norvegicus OX=10116 GN=Taar9 PE=2 SV=1,,,,,,
OG_06998,0.2570304903333627,FUN_032147-T1,Peve_00007908,Pocillopora_meandrina_HIv1___RNAseq.g5342.t1,three_way,65.17866666666666,FUN_032147-T1,Q3U435,MMP25_MOUSE,,Matrix metalloproteinase-25 (MMP-25) (EC 3.4.24.-),Mus musculus (Mouse),37.3,566.0,7.6e-77,289.7,sp|Q3U435|MMP25_MOUSE Matrix metalloproteinase-25 OS=Mus musculus OX=10090 GN=Mmp25 PE=2 SV=1,GO:0004222; GO:0005886; GO:0006508; GO:0008270; GO:0009986; GO:0016504; GO:0031012; GO:0060022; GO:0098552,hard palate development [GO:0060022]; proteolysis [GO:0006508],cell surface [GO:0009986]; extracellular matrix [GO:0031012]; plasma membrane [GO:0005886]; side of membrane [GO:0098552],metalloendopeptidase activity [GO:0004222]; peptidase activator activity [GO:0016504]; zinc ion binding [GO:0008270],GO:0003824; GO:0005886; GO:0016787; GO:0030312; GO:0031012; GO:0048856; GO:0098772; GO:0140096,"catalytic activity; plasma membrane; hydrolase activity; external encapsulating structure; extracellular matrix; anatomical structure development; molecular function regulator activity; catalytic activity, acting on a protein"
OG_06132,0.256668955902758,FUN_027938-T2,Peve_00032459,Pocillopora_meandrina_HIv1___RNAseq.g14030.t1,three_way,71.97066666666667,,,,,,,,,,,,,,,,,
OG_05136,0.2560955819309171,FUN_023407-T1,Peve_00016102,Pocillopora_meandrina_HIv1___RNAseq.g17552.t1,three_way,89.46416666666667,FUN_023407-T1,P24032,,,,,63.5,170.0,1.6e-54,213.8,"sp|P24032|MLRN_CHICK Myosin regulatory light chain 2, smooth muscle minor isoform OS=Gallus gallus OX=9031 PE=1 SV=2",,,,,,
OG_05031,0.2552352819308318,FUN_023205-T1,Peve_00010002,Pocillopora_meandrina_HIv1___RNAseq.g681.t2,three_way,61.8175,FUN_023205-T1,Q9H4G4,GAPR1_HUMAN,,Golgi-associated plant pathogenesis-related protein 1 (GAPR-1) (Golgi-associated PR-1 protein) (Glioma pathogenesis-related protein 2) (GliPR 2),Homo sapiens (Human),41.3,150.0,3.5e-26,119.8,sp|Q9H4G4|GAPR1_HUMAN Golgi-associated plant pathogenesis-related protein 1 OS=Homo sapiens OX=9606 GN=GLIPR2 PE=1 SV=3,GO:0000139; GO:0005615; GO:0010634; GO:0010718; GO:0019953; GO:0042803; GO:0070062; GO:0070374,positive regulation of epithelial cell migration [GO:0010634]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; sexual reproduction [GO:0019953],extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139],protein homodimerization activity [GO:0042803],GO:0005615; GO:0022414; GO:0043226,extracellular space; reproductive process; organelle
OG_02338,0.254395994330748,FUN_008934-T1,Peve_00036402,Pocillopora_meandrina_HIv1___RNAseq.g14257.t1,three_way,76.08966666666667,FUN_008934-T1,A5D7I4,EXT1_BOVIN,,Exostosin-1 (EC 2.4.1.225) (N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase),Bos taurus (Bovine),50.3,749.0,7.999999999999999e-217,755.0,sp|A5D7I4|EXT1_BOVIN Exostosin-1 OS=Bos taurus OX=9913 GN=EXT1 PE=2 SV=1,GO:0000139; GO:0000271; GO:0001958; GO:0001974; GO:0002067; GO:0002524; GO:0003128; GO:0003415; GO:0003416; GO:0005783; GO:0005789; GO:0005794; GO:0006024; GO:0006486; GO:0007033; GO:0007369; GO:0007411; GO:0007492; GO:0007498; GO:0008217; GO:0008375; GO:0008543; GO:0009642; GO:0010467; GO:0010803; GO:0014033; GO:0015012; GO:0015020; GO:0017145; GO:0019882; GO:0021554; GO:0021772; GO:0030163; GO:0030199; GO:0030210; GO:0030509; GO:0031069; GO:0032836; GO:0033627; GO:0035176; GO:0035249; GO:0035264; GO:0035988; GO:0036022; GO:0036336; GO:0036339; GO:0042044; GO:0042060; GO:0042311; GO:0042596; GO:0042803; GO:0043931; GO:0045165; GO:0045202; GO:0045453; GO:0046872; GO:0046982; GO:0048733; GO:0050508; GO:0050509; GO:0050891; GO:0050901; GO:0051923; GO:0055078; GO:0060047; GO:0060070; GO:0060218; GO:0060351; GO:0060441; GO:0060506; GO:0060560; GO:0060792; GO:0061484; GO:0061744; GO:0061974; GO:0062094; GO:0065003; GO:0070593; GO:0071503; GO:0071625; GO:0071711; GO:0072112; GO:0072498; GO:0097021; GO:0097241; GO:0098586; GO:0120193; GO:1901706; GO:1902494; GO:1904888; GO:1990823,"antigen processing and presentation [GO:0019882]; axon guidance [GO:0007411]; basement membrane organization [GO:0071711]; blood vessel remodeling [GO:0001974]; BMP signaling pathway [GO:0030509]; bone resorption [GO:0045453]; canonical Wnt signaling pathway [GO:0060070]; cartilage development involved in endochondral bone morphogenesis [GO:0060351]; cell adhesion mediated by integrin [GO:0033627]; cell fate commitment [GO:0045165]; cellular response to virus [GO:0098586]; chondrocyte hypertrophy [GO:0003415]; chondrocyte proliferation [GO:0035988]; collagen fibril organization [GO:0030199]; cranial skeletal system development [GO:1904888]; dendrite self-avoidance [GO:0070593]; dendritic cell migration [GO:0036336]; developmental growth involved in morphogenesis [GO:0060560]; embryonic skeletal joint development [GO:0072498]; endochondral bone growth [GO:0003416]; endochondral ossification [GO:0001958]; endoderm development [GO:0007492]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; fear response [GO:0042596]; fibroblast growth factor receptor signaling pathway [GO:0008543]; fluid transport [GO:0042044]; gastrulation [GO:0007369]; gene expression [GO:0010467]; glandular epithelial cell differentiation [GO:0002067]; glomerular basement membrane development [GO:0032836]; glycosaminoglycan biosynthetic process [GO:0006024]; hair follicle morphogenesis [GO:0031069]; heart contraction [GO:0060047]; heart field specification [GO:0003128]; hematopoietic stem cell differentiation [GO:0060218]; hematopoietic stem cell homeostasis [GO:0061484]; hematopoietic stem cell migration to bone marrow [GO:0097241]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; heparin proteoglycan biosynthetic process [GO:0030210]; hypersensitivity [GO:0002524]; leukocyte tethering or rolling [GO:0050901]; limb joint morphogenesis [GO:0036022]; lymphocyte adhesion to endothelial cell of high endothelial venule [GO:0036339]; lymphocyte migration into lymphoid organs [GO:0097021]; mesenchymal cell differentiation involved in bone development [GO:1901706]; mesoderm development [GO:0007498]; motor behavior [GO:0061744]; multicellular organism growth [GO:0035264]; multicellular organismal-level water homeostasis [GO:0050891]; neural crest cell differentiation [GO:0014033]; olfactory bulb development [GO:0021772]; optic nerve development [GO:0021554]; ossification involved in bone maturation [GO:0043931]; perichondral bone morphogenesis [GO:0061974]; podocyte differentiation [GO:0072112]; polysaccharide biosynthetic process [GO:0000271]; protein catabolic process [GO:0030163]; protein glycosylation [GO:0006486]; protein-containing complex assembly [GO:0065003]; regulation of blood pressure [GO:0008217]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]; response to heparin [GO:0071503]; response to leukemia inhibitory factor [GO:1990823]; response to light intensity [GO:0009642]; sebaceous gland development [GO:0048733]; smoothened signaling pathway involved in lung development [GO:0060506]; social behavior [GO:0035176]; sodium ion homeostasis [GO:0055078]; stem cell division [GO:0017145]; stomach development [GO:0062094]; sulfation [GO:0051923]; sweat gland development [GO:0060792]; synaptic transmission, glutamatergic [GO:0035249]; tight junction organization [GO:0120193]; vacuole organization [GO:0007033]; vasodilation [GO:0042311]; vocalization behavior [GO:0071625]; wound healing [GO:0042060]",catalytic complex [GO:1902494]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; synapse [GO:0045202],acetylglucosaminyltransferase activity [GO:0008375]; glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity [GO:0050508]; glucuronosyltransferase activity [GO:0015020]; metal ion binding [GO:0046872]; N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity [GO:0050509]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803],GO:0002376; GO:0003013; GO:0003824; GO:0005783; GO:0005794; GO:0005975; GO:0006486; GO:0006790; GO:0006954; GO:0007155; GO:0009101; GO:0016740; GO:0023052; GO:0030154; GO:0030163; GO:0030198; GO:0034330; GO:0042060; GO:0043226; GO:0048856; GO:0048870; GO:0065003; GO:1901135,immune system process; circulatory system process; catalytic activity; endoplasmic reticulum; Golgi apparatus; carbohydrate metabolic process; protein glycosylation; sulfur compound metabolic process; inflammatory response; cell adhesion; glycoprotein biosynthetic process; transferase activity; signaling; cell differentiation; protein catabolic process; extracellular matrix organization; cell junction organization; wound healing; organelle; anatomical structure development; cell motility; protein-containing complex assembly; carbohydrate derivative metabolic process
OG_05644,0.2534785816806852,FUN_025362-T1,Peve_00040527,Pocillopora_meandrina_HIv1___RNAseq.g13347.t1,three_way,93.85966666666668,FUN_025362-T1,Q5PQN7,,,,,68.9,190.0,6.3e-62,238.8,sp|Q5PQN7|LZIC_RAT Protein LZIC OS=Rattus norvegicus OX=10116 GN=Lzic PE=2 SV=1,,,,,,
OG_02012,0.252446959249395,FUN_008185-T1,Peve_00018749,Pocillopora_meandrina_HIv1___RNAseq.g29992.t1,three_way,52.86033333333334,FUN_008185-T1,O57382,,,,,29.0,317.0,5.399999999999999e-31,137.5,sp|O57382|TLL2_XENLA Tolloid-like protein 2 OS=Xenopus laevis OX=8355 GN=tll2 PE=2 SV=1,,,,,,
OG_00304,0.2497618474363378,FUN_001106-T1,Peve_00003165,Pocillopora_meandrina_HIv1___RNAseq.g29367.t1b,three_way,75.54033333333334,,,,,,,,,,,,,,,,,
OG_08229,0.2464720236566125,FUN_036101-T1,Peve_00032197,Pocillopora_meandrina_HIv1___RNAseq.g10817.t1,three_way,53.59666666666666,,,,,,,,,,,,,,,,,
OG_07251,0.2463163457895242,FUN_032993-T1,Peve_00014539,Pocillopora_meandrina_HIv1___RNAseq.g24472.t1,three_way,86.36833333333334,FUN_032993-T1,P47826,,,,,72.1,280.0,9.999999999999999e-116,417.9,sp|P47826|RLA0_CHICK Large ribosomal subunit protein uL10 OS=Gallus gallus OX=9031 GN=RPLP0 PE=1 SV=1,,,,,,
OG_05585,0.2460540342299613,FUN_024916-T1,Peve_00007311,Pocillopora_meandrina_HIv1___RNAseq.g22868.t1,three_way,51.687666666666665,,,,,,,,,,,,,,,,,
OG_09596,0.2445114780282449,FUN_041743-T1,Peve_00002188,Pocillopora_meandrina_HIv1___RNAseq.g15788.t1,three_way,64.87933333333334,,,,,,,,,,,,,,,,,
OG_09894,0.2444180444220229,FUN_042988-T1,Peve_00036062,Pocillopora_meandrina_HIv1___RNAseq.g7093.t1,three_way,53.70933333333333,,,,,,,,,,,,,,,,,
OG_07929,0.2441674796840264,FUN_035418-T1,Peve_00039851,Pocillopora_meandrina_HIv1___RNAseq.g27566.t1,three_way,69.55066666666667,FUN_035418-T1,B8AJ09,,,,,28.2,312.0,1.7e-16,88.6,"sp|B8AJ09|BASS4_ORYSI Probable sodium/metabolite cotransporter BASS4, chloroplastic OS=Oryza sativa subsp. indica OX=39946 GN=BASS4 PE=3 SV=1",,,,,,
OG_07731,0.243607817962504,FUN_034892-T1,Peve_00037338,Pocillopora_meandrina_HIv1___TS.g15150.t1,three_way,61.52,,,,,,,,,,,,,,,,,
OG_04999,0.2416501419547767,FUN_023134-T1,Peve_00008524,Pocillopora_meandrina_HIv1___RNAseq.g1753.t1,three_way,84.611,FUN_023134-T1,P26632,EGR1_DANRE,,Early growth response protein 1 (EGR-1) (Zinc finger protein Krox-24),Danio rerio (Zebrafish) (Brachydanio rerio),46.4,125.0,1.4e-15,85.5,sp|P26632|EGR1_DANRE Early growth response protein 1 OS=Danio rerio OX=7955 GN=egr1 PE=2 SV=2,GO:0000978; GO:0000981; GO:0005634; GO:0005737; GO:0006357; GO:0008270; GO:0010385; GO:0010842; GO:0032922; GO:0043010; GO:0043565; GO:0044729; GO:0045893; GO:0045944; GO:0048703; GO:0060059; GO:1990841,camera-type eye development [GO:0043010]; circadian regulation of gene expression [GO:0032922]; embryonic retina morphogenesis in camera-type eye [GO:0060059]; embryonic viscerocranium morphogenesis [GO:0048703]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; retina layer formation [GO:0010842],cytoplasm [GO:0005737]; nucleus [GO:0005634],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; double-stranded methylated DNA binding [GO:0010385]; hemi-methylated DNA-binding [GO:0044729]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]",GO:0003677; GO:0005634; GO:0006355; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; organelle; anatomical structure development; transcription regulator activity
OG_06436,0.2402163157445008,FUN_029130-T1,Peve_00033155,Pocillopora_meandrina_HIv1___RNAseq.g25785.t1,three_way,48.33016666666666,,,,,,,,,,,,,,,,,
OG_08937,0.2389646906820753,FUN_038401-T1,Peve_00000033,Pocillopora_meandrina_HIv1___RNAseq.g28276.t1,three_way,76.06083333333333,FUN_038401-T1,Q9BG91,,,,,65.5,148.0,5e-50,200.3,sp|Q9BG91|SOX9_CALJA Transcription factor SOX-9 OS=Callithrix jacchus OX=9483 GN=SOX9 PE=2 SV=1,,,,,,
OG_03099,0.2385920201947624,FUN_012386-T1,Peve_00030648,Pocillopora_meandrina_HIv1___RNAseq.g23347.t1,three_way,52.83716666666666,,,,,,,,,,,,,,,,,
OG_09075,0.2384919194456737,FUN_038804-T1,Peve_00007218,Pocillopora_meandrina_HIv1___RNAseq.g28539.t1c,three_way,93.94983333333332,FUN_038804-T1,Q90YS3,,,,,88.7,231.0,2.5e-113,409.8,sp|Q90YS3|RS2_ICTPU Small ribosomal subunit protein uS5 OS=Ictalurus punctatus OX=7998 GN=rps2 PE=2 SV=1,,,,,,
OG_04559,0.2373896892970636,FUN_022198-T1,Peve_00038010,Pocillopora_meandrina_HIv1___RNAseq.g4797.t1,three_way,68.02633333333333,,,,,,,,,,,,,,,,,
OG_04609,0.2373107943074555,FUN_022305-T1,Peve_00003816,Pocillopora_meandrina_HIv1___RNAseq.g3971.t1,three_way,36.00233333333333,,,,,,,,,,,,,,,,,
OG_05938,0.2367557836899206,FUN_026173-T1,Peve_00039168,Pocillopora_meandrina_HIv1___RNAseq.g3177.t1,three_way,35.60133333333333,FUN_026173-T1,P24668,MPRD_MOUSE,,Cation-dependent mannose-6-phosphate receptor (CD Man-6-P receptor) (CD-MPR) (46 kDa mannose 6-phosphate receptor) (MPR 46),Mus musculus (Mouse),51.8,56.0,7e-07,56.2,sp|P24668|MPRD_MOUSE Cation-dependent mannose-6-phosphate receptor OS=Mus musculus OX=10090 GN=M6pr PE=1 SV=1,GO:0005765; GO:0005768; GO:0005770; GO:0005794; GO:0006622; GO:0006886; GO:0007041; GO:0019904; GO:0033299; GO:0048471; GO:1905394,intracellular protein transport [GO:0006886]; lysosomal transport [GO:0007041]; protein targeting to lysosome [GO:0006622]; secretion of lysosomal enzymes [GO:0033299],endosome [GO:0005768]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; perinuclear region of cytoplasm [GO:0048471],protein domain specific binding [GO:0019904]; retromer complex binding [GO:1905394],GO:0005768; GO:0005794; GO:0006886; GO:0031410; GO:0043226,endosome; Golgi apparatus; intracellular protein transport; cytoplasmic vesicle; organelle
OG_01472,0.2366424608503688,FUN_006009-T1,Peve_00032112,Pocillopora_meandrina_HIv1___RNAseq.g28362.t1,three_way,43.14983333333333,,,,,,,,,,,,,,,,,
OG_01250,0.2349279839157985,FUN_004969-T1,Peve_00043270,Pocillopora_meandrina_HIv1___TS.g20136.t1,three_way,49.14716666666666,,,,,,,,,,,,,,,,,
OG_08984,0.2347126105199235,FUN_038503-T1,Peve_00041694,Pocillopora_meandrina_HIv1___RNAseq.g28159.t1,three_way,62.70366666666667,,,,,,,,,,,,,,,,,
OG_02101,0.2343797945263859,FUN_008377-T1,Peve_00024686,Pocillopora_meandrina_HIv1___RNAseq.g18396.t1,three_way,53.3375,,,,,,,,,,,,,,,,,
OG_03429,0.2315907203467742,FUN_014485-T1,Peve_00037303,Pocillopora_meandrina_HIv1___RNAseq.g22811.t1,three_way,75.97416666666666,FUN_014485-T1,O35887,,,,,29.0,155.0,5.5e-09,63.5,sp|O35887|CALU_MOUSE Calumenin OS=Mus musculus OX=10090 GN=Calu PE=1 SV=1,,,,,,
OG_03335,0.2315466528551881,FUN_013556-T1,Peve_00038569,Pocillopora_meandrina_HIv1___RNAseq.g22960.t1,three_way,59.44166666666667,FUN_013556-T1,Q6NR09,EGRAP_DROME,,EGFR adapter protein,Drosophila melanogaster (Fruit fly),34.3,137.0,7.7e-13,77.0,sp|Q6NR09|EGRAP_DROME EGFR adapter protein OS=Drosophila melanogaster OX=7227 GN=Egfrap PE=1 SV=1,GO:0005925; GO:0030971; GO:0042059; GO:0045179,negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059],apical cortex [GO:0045179]; focal adhesion [GO:0005925],receptor tyrosine kinase binding [GO:0030971],,
OG_05531,0.2312495131250391,FUN_024682-T1,Peve_00012723,Pocillopora_meandrina_HIv1___RNAseq.g18950.t1,three_way,76.55683333333333,FUN_024682-T1,Q17QB7,RAB30_BOVIN,,Ras-related protein Rab-30 (EC 3.6.5.2),Bos taurus (Bovine),53.8,184.0,3.0999999999999996e-55,216.5,sp|Q17QB7|RAB30_BOVIN Ras-related protein Rab-30 OS=Bos taurus OX=9913 GN=RAB30 PE=2 SV=1,GO:0003924; GO:0005525; GO:0005801; GO:0005802; GO:0007030; GO:0016020; GO:0016192; GO:0031985; GO:0032482,Golgi organization [GO:0007030]; Rab protein signal transduction [GO:0032482]; vesicle-mediated transport [GO:0016192],cis-Golgi network [GO:0005801]; Golgi cisterna [GO:0031985]; membrane [GO:0016020]; trans-Golgi network [GO:0005802],GTP binding [GO:0005525]; GTPase activity [GO:0003924],GO:0003824; GO:0003924; GO:0016192; GO:0016787; GO:0043226,catalytic activity; GTPase activity; vesicle-mediated transport; hydrolase activity; organelle
OG_07807,0.2309353683219868,FUN_035052-T1,Peve_00011121,Pocillopora_meandrina_HIv1___RNAseq.g27741.t1,three_way,68.56233333333333,FUN_035052-T1,Q9C2L8,,,,,29.8,168.0,2.7e-14,80.5,sp|Q9C2L8|RAB7_NEUCR Ypt/Rab-type GTPase Rab7 OS=Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) OX=367110 GN=gtp-14 PE=3 SV=1,,,,,,
OG_08967,0.2309048663726171,FUN_038472-T1,Peve_00039876,Pocillopora_meandrina_HIv1___RNAseq.g28229.t1,three_way,51.10716666666666,,,,,,,,,,,,,,,,,
OG_08098,0.2305886193359692,FUN_035840-T1,Peve_00032502,Pocillopora_meandrina_HIv1___RNAseq.g11957.t1,three_way,76.54033333333332,FUN_035840-T1,P38532,HSF1_MOUSE,,Heat shock factor protein 1 (HSF 1) (Heat shock transcription factor 1) (HSTF 1),Mus musculus (Mouse),55.7,176.0,1.1e-44,182.6,sp|P38532|HSF1_MOUSE Heat shock factor protein 1 OS=Mus musculus OX=10090 GN=Hsf1 PE=1 SV=2,GO:0000122; GO:0000165; GO:0000776; GO:0000791; GO:0000792; GO:0000978; GO:0001162; GO:0001227; GO:0001228; GO:0001701; GO:0001892; GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0006281; GO:0006397; GO:0006952; GO:0007143; GO:0007283; GO:0007584; GO:0008283; GO:0009408; GO:0010628; GO:0010667; GO:0014823; GO:0016605; GO:0019901; GO:0031072; GO:0031333; GO:0031490; GO:0032496; GO:0032720; GO:0032991; GO:0033574; GO:0034605; GO:0034620; GO:0035865; GO:0040018; GO:0042802; GO:0043565; GO:0045120; GO:0045651; GO:0045931; GO:0045944; GO:0046982; GO:0048471; GO:0050673; GO:0050680; GO:0051028; GO:0051879; GO:0060136; GO:0061770; GO:0062029; GO:0065003; GO:0070301; GO:0071222; GO:0071276; GO:0071280; GO:0071392; GO:0071466; GO:0071480; GO:0072738; GO:0090084; GO:0090261; GO:0097165; GO:0097431; GO:0097677; GO:0098847; GO:0101031; GO:0120162; GO:0140296; GO:1900034; GO:1901652; GO:1902512; GO:1903936; GO:1904385; GO:1904843; GO:1904845; GO:1990841; GO:1990904; GO:1990910; GO:1990911; GO:2001033; GO:2001235,cell population proliferation [GO:0008283]; cellular response to angiotensin [GO:1904385]; cellular response to cadmium ion [GO:0071276]; cellular response to copper ion [GO:0071280]; cellular response to diamide [GO:0072738]; cellular response to estradiol stimulus [GO:0071392]; cellular response to gamma radiation [GO:0071480]; cellular response to heat [GO:0034605]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to L-glutamine [GO:1904845]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to nitroglycerin [GO:1904843]; cellular response to potassium ion [GO:0035865]; cellular response to sodium arsenite [GO:1903936]; cellular response to unfolded protein [GO:0034620]; cellular response to xenobiotic stimulus [GO:0071466]; defense response [GO:0006952]; DNA repair [GO:0006281]; embryonic placenta development [GO:0001892]; embryonic process involved in female pregnancy [GO:0060136]; epithelial cell proliferation [GO:0050673]; female meiotic nuclear division [GO:0007143]; in utero embryonic development [GO:0001701]; MAPK cascade [GO:0000165]; mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of double-strand break repair via nonhomologous end joining [GO:2001033]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of inclusion body assembly [GO:0090084]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of tumor necrosis factor production [GO:0032720]; positive regulation of apoptotic DNA fragmentation [GO:1902512]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of gene expression [GO:0010628]; positive regulation of inclusion body assembly [GO:0090261]; positive regulation of macrophage differentiation [GO:0045651]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of stress granule assembly [GO:0062029]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein-containing complex assembly [GO:0065003]; regulation of cellular response to heat [GO:1900034]; response to activity [GO:0014823]; response to heat [GO:0009408]; response to hypobaric hypoxia [GO:1990910]; response to lipopolysaccharide [GO:0032496]; response to nutrient [GO:0007584]; response to peptide [GO:1901652]; response to psychosocial stress [GO:1990911]; response to testosterone [GO:0033574]; spermatogenesis [GO:0007283],centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; euchromatin [GO:0000791]; heterochromatin [GO:0000792]; kinetochore [GO:0000776]; mitotic spindle pole [GO:0097431]; nuclear stress granule [GO:0097165]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; PML body [GO:0016605]; pronucleus [GO:0045120]; protein folding chaperone complex [GO:0101031]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904],"chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; general transcription initiation factor binding [GO:0140296]; heat shock protein binding [GO:0031072]; Hsp90 protein binding [GO:0051879]; identical protein binding [GO:0042802]; promoter-specific chromatin binding [GO:1990841]; protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding [GO:0001162]; sequence-specific DNA binding [GO:0043565]; sequence-specific single stranded DNA binding [GO:0098847]; STAT family protein binding [GO:0097677]; translation elongation factor binding [GO:0061770]",GO:0003677; GO:0005634; GO:0005654; GO:0005815; GO:0005829; GO:0006281; GO:0006355; GO:0016071; GO:0022414; GO:0043226; GO:0048856; GO:0065003; GO:0140013; GO:0140110,DNA binding; nucleus; nucleoplasm; microtubule organizing center; cytosol; DNA repair; regulation of DNA-templated transcription; mRNA metabolic process; reproductive process; organelle; anatomical structure development; protein-containing complex assembly; meiotic nuclear division; transcription regulator activity
OG_02532,0.2300217945815246,FUN_010610-T1,Peve_00002553,Pocillopora_meandrina_HIv1___RNAseq.g9919.t1,three_way,68.22433333333333,,,,,,,,,,,,,,,,,
OG_01636,0.2277760203758742,FUN_006769-T1,Peve_00027411,Pocillopora_meandrina_HIv1___RNAseq.g20028.t1,three_way,57.7305,FUN_006769-T1,Q9Y2U8,MAN1_HUMAN,,Inner nuclear membrane protein Man1 (LEM domain-containing protein 3),Homo sapiens (Human),42.9,317.0,7.4e-55,216.9,sp|Q9Y2U8|MAN1_HUMAN Inner nuclear membrane protein Man1 OS=Homo sapiens OX=9606 GN=LEMD3 PE=1 SV=2,GO:0003677; GO:0005637; GO:0016020; GO:0030512; GO:0030514; GO:0031965; GO:0032926; GO:1990446,negative regulation of activin receptor signaling pathway [GO:0032926]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512],membrane [GO:0016020]; nuclear inner membrane [GO:0005637]; nuclear membrane [GO:0031965],DNA binding [GO:0003677]; U1 snRNP binding [GO:1990446],GO:0003677,DNA binding
OG_07400,0.2255800604157792,FUN_033839-T1,Peve_00016490,Pocillopora_meandrina_HIv1___RNAseq.g26367.t1,three_way,53.79466666666666,,,,,,,,,,,,,,,,,
OG_04476,0.2253185593114846,FUN_020920-T1,Peve_00017285,Pocillopora_meandrina_HIv1___RNAseq.g15907.t1a,three_way,47.4085,FUN_020920-T1,O95450,,,,,28.7,905.0,8.1e-97,356.7,sp|O95450|ATS2_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 2 OS=Homo sapiens OX=9606 GN=ADAMTS2 PE=1 SV=2,,,,,,
OG_08842,0.2249474730376509,FUN_038187-T1,Peve_00006347,Pocillopora_meandrina_HIv1___RNAseq.g945.t1,three_way,61.87833333333334,FUN_038187-T1,Q80ZA4,PKHL1_MOUSE,,Fibrocystin-L (Polycystic kidney and hepatic disease 1-like protein 1) (PKHD1-like protein 1) (Protein D86),Mus musculus (Mouse),34.3,4297.0,0.0,2329.7,sp|Q80ZA4|PKHL1_MOUSE Fibrocystin-L OS=Mus musculus OX=10090 GN=Pkhd1l1 PE=1 SV=1,GO:0007605; GO:0032426; GO:0060171; GO:0120234,sensory perception of sound [GO:0007605],stereocilium coat [GO:0120234]; stereocilium membrane [GO:0060171]; stereocilium tip [GO:0032426],,GO:0030312; GO:0050877,external encapsulating structure; nervous system process
OG_06909,0.224497308391841,FUN_031967-T1,Peve_00013260,Pocillopora_meandrina_HIv1___RNAseq.g17806.t1,three_way,83.551,FUN_031967-T1,Q95M17,CHIA_BOVIN,,Acidic mammalian chitinase (AMCase) (EC 3.2.1.14) (Chitin-binding protein b04) (CBPb04),Bos taurus (Bovine),46.4,390.0,4.3999999999999996e-91,336.7,sp|Q95M17|CHIA_BOVIN Acidic mammalian chitinase OS=Bos taurus OX=9913 GN=CHIA PE=1 SV=1,GO:0000272; GO:0002376; GO:0002532; GO:0004568; GO:0005576; GO:0005615; GO:0005737; GO:0006032; GO:0006915; GO:0008061; GO:0008843; GO:0032722,apoptotic process [GO:0006915]; chitin catabolic process [GO:0006032]; immune system process [GO:0002376]; polysaccharide catabolic process [GO:0000272]; positive regulation of chemokine production [GO:0032722]; production of molecular mediator involved in inflammatory response [GO:0002532],cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615],chitin binding [GO:0008061]; chitinase activity [GO:0004568]; endochitinase activity [GO:0008843],GO:0002376; GO:0003824; GO:0005576; GO:0005615; GO:0005975; GO:0012501; GO:0016787; GO:1901135,immune system process; catalytic activity; extracellular region; extracellular space; carbohydrate metabolic process; programmed cell death; hydrolase activity; carbohydrate derivative metabolic process
OG_06234,0.2238984866050125,FUN_028187-T1,Peve_00000861,Pocillopora_meandrina_HIv1___RNAseq.g16542.t1,three_way,56.39333333333333,FUN_028187-T1,Q9YH85,,,,,27.1,284.0,4.2e-15,84.0,sp|Q9YH85|TECTA_CHICK Alpha-tectorin OS=Gallus gallus OX=9031 GN=TECTA PE=1 SV=1,,,,,,
OG_07394,0.2229062957389175,FUN_033824-T1,Peve_00028770,Pocillopora_meandrina_HIv1___RNAseq.g26355.t1,three_way,53.976,,,,,,,,,,,,,,,,,
OG_08611,0.2228999632613164,FUN_037758-T1,Peve_00014340,Pocillopora_meandrina_HIv1___RNAseq.g1498.t1,three_way,47.662333333333336,,,,,,,,,,,,,,,,,
OG_08392,0.2226090759506119,FUN_037004-T1,Peve_00002158,Pocillopora_meandrina_HIv1___RNAseq.g26681.t1,three_way,58.53766666666667,FUN_037004-T1,P98063,BMP1_MOUSE,,Bone morphogenetic protein 1 (BMP-1) (EC 3.4.24.19) (Mammalian tolloid protein) (mTld) (Procollagen C-proteinase) (PCP),Mus musculus (Mouse),35.2,267.0,1.5999999999999998e-41,172.9,sp|P98063|BMP1_MOUSE Bone morphogenetic protein 1 OS=Mus musculus OX=10090 GN=Bmp1 PE=1 SV=2,GO:0001503; GO:0004222; GO:0005125; GO:0005509; GO:0005615; GO:0005794; GO:0006508; GO:0008083; GO:0008233; GO:0008270; GO:0030154; GO:0031982; GO:0042802; GO:0051216; GO:0061036; GO:0062023,cartilage development [GO:0051216]; cell differentiation [GO:0030154]; ossification [GO:0001503]; positive regulation of cartilage development [GO:0061036]; proteolysis [GO:0006508],collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; vesicle [GO:0031982],calcium ion binding [GO:0005509]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; identical protein binding [GO:0042802]; metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233]; zinc ion binding [GO:0008270],GO:0003824; GO:0005615; GO:0005794; GO:0016787; GO:0030154; GO:0043226; GO:0048018; GO:0048856; GO:0098772; GO:0140096,"catalytic activity; extracellular space; Golgi apparatus; hydrolase activity; cell differentiation; organelle; receptor ligand activity; anatomical structure development; molecular function regulator activity; catalytic activity, acting on a protein"
OG_08731,0.222083794331441,FUN_037988-T1,Peve_00025059,Pocillopora_meandrina_HIv1___RNAseq.g26272.t1,three_way,38.300666666666665,,,,,,,,,,,,,,,,,
OG_02929,0.2218133550211254,FUN_012028-T1,Peve_00030379,Pocillopora_meandrina_HIv1___RNAseq.g24047.t2,three_way,77.09433333333334,FUN_012028-T1,Q14192,FHL2_HUMAN,,Four and a half LIM domains protein 2 (FHL-2) (LIM domain protein DRAL) (Skeletal muscle LIM-protein 3) (SLIM-3),Homo sapiens (Human),42.1,273.0,1.7000000000000002e-74,282.0,sp|Q14192|FHL2_HUMAN Four and a half LIM domains protein 2 OS=Homo sapiens OX=9606 GN=FHL2 PE=1 SV=3,GO:0000122; GO:0001649; GO:0003714; GO:0005634; GO:0005654; GO:0005925; GO:0008134; GO:0008270; GO:0009725; GO:0030018; GO:0042802; GO:0043066; GO:0043425; GO:0055014; GO:0055015; GO:0060347; GO:0070885,atrial cardiac muscle cell development [GO:0055014]; heart trabecula formation [GO:0060347]; negative regulation of apoptotic process [GO:0043066]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of transcription by RNA polymerase II [GO:0000122]; osteoblast differentiation [GO:0001649]; response to hormone [GO:0009725]; ventricular cardiac muscle cell development [GO:0055015],focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Z disc [GO:0030018],bHLH transcription factor binding [GO:0043425]; identical protein binding [GO:0042802]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; zinc ion binding [GO:0008270],GO:0005634; GO:0005654; GO:0006355; GO:0030154; GO:0043226; GO:0048856; GO:0060090; GO:0140110,nucleus; nucleoplasm; regulation of DNA-templated transcription; cell differentiation; organelle; anatomical structure development; molecular adaptor activity; transcription regulator activity
OG_06956,0.2215604926584189,FUN_032081-T1,Peve_00039910,Pocillopora_meandrina_HIv1___RNAseq.g5227.t1,three_way,79.99466666666666,FUN_032081-T1,Q5RE98,AOFB_PONAB,,Amine oxidase [flavin-containing] B (EC 1.4.3.21) (EC 1.4.3.4) (Monoamine oxidase type B) (MAO-B),Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),47.7,486.0,1.1000000000000001e-130,468.4,sp|Q5RE98|AOFB_PONAB Amine oxidase [flavin-containing] B OS=Pongo abelii OX=9601 GN=MAOB PE=2 SV=3,GO:0005739; GO:0005741; GO:0008131; GO:0050660; GO:0097621,,mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739],flavin adenine dinucleotide binding [GO:0050660]; monoamine oxidase activity [GO:0097621]; primary methylamine oxidase activity [GO:0008131],GO:0003824; GO:0005739; GO:0016491; GO:0043226,catalytic activity; mitochondrion; oxidoreductase activity; organelle
OG_02502,0.2210461277172399,FUN_009857-T2,Peve_00009100,Pocillopora_meandrina_HIv1___RNAseq.g24506.t1,three_way,84.31183333333333,FUN_009857-T2,Q92005,,,,,85.1,462.0,2.1999999999999998e-231,802.7,sp|Q92005|EF1A_DANRE Elongation factor 1-alpha OS=Danio rerio OX=7955 GN=eef1a PE=2 SV=1,,,,,,
OG_06554,0.2204647361564879,FUN_029431-T1,Peve_00039461,Pocillopora_meandrina_HIv1___RNAseq.g17172.t1,three_way,70.55433333333333,,,,,,,,,,,,,,,,,
OG_09091,0.2203385913567098,FUN_038889-T1,Peve_00028699,Pocillopora_meandrina_HIv1___RNAseq.g28663.t1,three_way,51.704,,,,,,,,,,,,,,,,,
OG_02226,0.2203340817604277,FUN_008631-T1,Peve_00012388,Pocillopora_meandrina_HIv1___RNAseq.g14912.t1,three_way,62.56166666666666,,,,,,,,,,,,,,,,,
OG_06291,0.2196578324100818,FUN_028486-T1,Peve_00039740,Pocillopora_meandrina_HIv1___TS.g11105.t3a,three_way,50.81666666666667,FUN_028486-T1,A6QLU6,AGRD1_BOVIN,,"Adhesion G-protein coupled receptor D1 (G-protein coupled receptor 133) [Cleaved into: Adhesion G-protein coupled receptor D1, N-terminal fragment (ADGRD1 N-terminal fragment); Adhesion G-protein coupled receptor D1, C-terminal fragment (ADGRD1 C-terminal fragment)]",Bos taurus (Bovine),33.2,368.0,2.2e-41,172.6,sp|A6QLU6|AGRD1_BOVIN Adhesion G-protein coupled receptor D1 OS=Bos taurus OX=9913 GN=ADGRD1 PE=2 SV=1,GO:0004930; GO:0005886; GO:0007166; GO:0007186; GO:0007189,adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186],plasma membrane [GO:0005886],G protein-coupled receptor activity [GO:0004930],GO:0005886; GO:0060089,plasma membrane; molecular transducer activity
OG_04508,0.2193357695755284,FUN_022036-T1,Peve_00019003,Pocillopora_meandrina_HIv1___RNAseq.g9285.t1,three_way,61.077333333333335,,,,,,,,,,,,,,,,,
OG_00957,0.2179553244172091,FUN_004321-T1,Peve_00016506,Pocillopora_meandrina_HIv1___RNAseq.g11786.t1,three_way,75.91266666666667,FUN_004321-T1,P54357,,,,,42.0,143.0,3.7e-23,109.4,sp|P54357|MLC2_DROME Myosin-2 essential light chain OS=Drosophila melanogaster OX=7227 GN=Mlc-c PE=1 SV=1,,,,,,
OG_08941,0.217889488650096,FUN_038410-T1,Peve_00000012,Pocillopora_meandrina_HIv1___RNAseq.g28285.t1,three_way,90.88266666666668,FUN_038410-T1,Q66IZ7,,,,,48.4,287.0,1.4e-49,198.4,sp|Q66IZ7|NDL1B_XENLA Nuclear distribution protein nudE-like 1-B OS=Xenopus laevis OX=8355 GN=ndel1-b PE=2 SV=1,,,,,,
OG_09627,0.2174130441340076,FUN_041794-T1,Peve_00009375,Pocillopora_meandrina_HIv1___RNAseq.g15767.t1,three_way,43.15016666666666,FUN_041794-T1,Q4VC17,ATS18_MOUSE,,A disintegrin and metalloproteinase with thrombospondin motifs 18 (ADAM-TS 18) (ADAM-TS18) (ADAMTS-18) (EC 3.4.24.-),Mus musculus (Mouse),27.2,1006.0,3.1e-77,292.0,sp|Q4VC17|ATS18_MOUSE A disintegrin and metalloproteinase with thrombospondin motifs 18 OS=Mus musculus OX=10090 GN=Adamts18 PE=2 SV=2,GO:0001654; GO:0004222; GO:0005576; GO:0006508; GO:0030198; GO:0046872; GO:0090331,extracellular matrix organization [GO:0030198]; eye development [GO:0001654]; negative regulation of platelet aggregation [GO:0090331]; proteolysis [GO:0006508],extracellular region [GO:0005576],metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222],GO:0003824; GO:0005576; GO:0016787; GO:0030198; GO:0048856; GO:0140096,"catalytic activity; extracellular region; hydrolase activity; extracellular matrix organization; anatomical structure development; catalytic activity, acting on a protein"
OG_03531,0.2171574097471909,FUN_014646-T1,Peve_00025654,Pocillopora_meandrina_HIv1___RNAseq.g22686.t1,three_way,77.64233333333333,FUN_014646-T1,Q9D1L0,,,,,56.7,60.0,7.4e-11,68.6,sp|Q9D1L0|CHCH2_MOUSE Coiled-coil-helix-coiled-coil-helix domain-containing protein 2 OS=Mus musculus OX=10090 GN=Chchd2 PE=2 SV=1,,,,,,
OG_08355,0.2167988840556649,FUN_036899-T1,Peve_00018371,Pocillopora_meandrina_HIv1___RNAseq.g26703.t1,three_way,78.23133333333332,FUN_036899-T1,Q8VZ42,,,,,40.3,129.0,1.3e-25,117.5,sp|Q8VZ42|SAP11_ARATH Zinc finger AN1 and C2H2 domain-containing stress-associated protein 11 OS=Arabidopsis thaliana OX=3702 GN=SAP11 PE=2 SV=1,,,,,,
OG_09826,0.2167023021538182,FUN_042659-T1,Peve_00031591,Pocillopora_meandrina_HIv1___RNAseq.g4898.t1,three_way,46.13633333333333,,,,,,,,,,,,,,,,,
OG_08928,0.2158246863213049,FUN_038386-T1,Peve_00000061,Pocillopora_meandrina_HIv1___RNAseq.g28288.t1,three_way,58.09316666666667,FUN_038386-T1,P16065,,,,,37.9,1080.0,5.1e-181,636.7,sp|P16065|GCY_STRPU Speract receptor OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1,,,,,,
OG_01645,0.2146581164559487,FUN_006796-T1,Peve_00019185,Pocillopora_meandrina_HIv1___RNAseq.g20496.t1,three_way,33.34466666666667,FUN_006796-T1,Q96RW7,HMCN1_HUMAN,,Hemicentin-1 (Fibulin-6) (FIBL-6),Homo sapiens (Human),28.9,287.0,1.3e-17,92.4,sp|Q96RW7|HMCN1_HUMAN Hemicentin-1 OS=Homo sapiens OX=9606 GN=HMCN1 PE=1 SV=2,GO:0005201; GO:0005509; GO:0005604; GO:0005737; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0030036; GO:0032154; GO:0051301; GO:0062023; GO:0070062; GO:0071711,actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601],adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; muscle tendon junction [GO:0005927],calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201],GO:0005198; GO:0007010; GO:0007155; GO:0030198; GO:0030312; GO:0031012; GO:0043226; GO:0050877,structural molecule activity; cytoskeleton organization; cell adhesion; extracellular matrix organization; external encapsulating structure; extracellular matrix; organelle; nervous system process
OG_09247,0.2146053154889423,FUN_040037-T1,Peve_00040431,Pocillopora_meandrina_HIv1___RNAseq.g8456.t1,three_way,47.013000000000005,FUN_040037-T1,P02788,TRFL_HUMAN,,Lactotransferrin (Lactoferrin) (EC 3.4.21.-) (Growth-inhibiting protein 12) (Talalactoferrin) [Cleaved into: Lactoferricin-H (Lfcin-H); Kaliocin-1; Lactoferroxin-A; Lactoferroxin-B; Lactoferroxin-C],Homo sapiens (Human),26.8,567.0,3.6e-34,149.1,sp|P02788|TRFL_HUMAN Lactotransferrin OS=Homo sapiens OX=9606 GN=LTF PE=1 SV=6,GO:0001503; GO:0001530; GO:0001817; GO:0002227; GO:0003677; GO:0004252; GO:0004869; GO:0005506; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0005769; GO:0005886; GO:0006508; GO:0006826; GO:0006959; GO:0008201; GO:0009986; GO:0019731; GO:0019732; GO:0030141; GO:0031640; GO:0031665; GO:0032680; GO:0032780; GO:0032991; GO:0033690; GO:0034145; GO:0035580; GO:0042581; GO:0043066; GO:0043123; GO:0043539; GO:0044793; GO:0045071; GO:0045669; GO:0048525; GO:0050829; GO:0051092; GO:0055037; GO:0060349; GO:0061844; GO:0070062; GO:0071902; GO:0097013; GO:0140912; GO:1900159; GO:1900229; GO:1902732; GO:1904724; GO:2000308; GO:2001205,antibacterial humoral response [GO:0019731]; antifungal humoral response [GO:0019732]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; bone morphogenesis [GO:0060349]; defense response to Gram-negative bacterium [GO:0050829]; humoral immune response [GO:0006959]; innate immune response in mucosa [GO:0002227]; iron ion transport [GO:0006826]; killing of cells of another organism [GO:0031640]; negative regulation by host of viral process [GO:0044793]; negative regulation of apoptotic process [GO:0043066]; negative regulation of ATP-dependent activity [GO:0032780]; negative regulation of lipopolysaccharide-mediated signaling pathway [GO:0031665]; negative regulation of osteoclast development [GO:2001205]; negative regulation of single-species biofilm formation in or on host organism [GO:1900229]; negative regulation of tumor necrosis factor (ligand) superfamily member 11 production [GO:2000308]; negative regulation of viral genome replication [GO:0045071]; negative regulation of viral process [GO:0048525]; ossification [GO:0001503]; positive regulation of bone mineralization involved in bone maturation [GO:1900159]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of chondrocyte proliferation [GO:1902732]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of toll-like receptor 4 signaling pathway [GO:0034145]; proteolysis [GO:0006508]; regulation of cytokine production [GO:0001817]; regulation of tumor necrosis factor production [GO:0032680],cell surface [GO:0009986]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleus [GO:0005634]; phagocytic vesicle lumen [GO:0097013]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; recycling endosome [GO:0055037]; secretory granule [GO:0030141]; specific granule [GO:0042581]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724],cysteine-type endopeptidase inhibitor activity [GO:0004869]; DNA binding [GO:0003677]; heparin binding [GO:0008201]; iron ion binding [GO:0005506]; lipopolysaccharide binding [GO:0001530]; membrane destabilizing activity [GO:0140912]; protein serine/threonine kinase activator activity [GO:0043539]; serine-type endopeptidase activity [GO:0004252],GO:0002376; GO:0003677; GO:0003824; GO:0005576; GO:0005615; GO:0005634; GO:0005768; GO:0005886; GO:0006355; GO:0008289; GO:0016787; GO:0031410; GO:0043226; GO:0098542; GO:0098772; GO:0140096,"immune system process; DNA binding; catalytic activity; extracellular region; extracellular space; nucleus; endosome; plasma membrane; regulation of DNA-templated transcription; lipid binding; hydrolase activity; cytoplasmic vesicle; organelle; defense response to other organism; molecular function regulator activity; catalytic activity, acting on a protein"
OG_09188,0.2139095049459858,FUN_039870-T1,Peve_00006913,Pocillopora_meandrina_HIv1___RNAseq.g7377.t1,three_way,54.30833333333333,,,,,,,,,,,,,,,,,
OG_04621,0.213745835246411,FUN_022323-T1,Peve_00021645,Pocillopora_meandrina_HIv1___RNAseq.g4644.t1,three_way,86.14483333333334,,,,,,,,,,,,,,,,,
OG_09295,0.2128309041892199,FUN_040146-T1,Peve_00038108,Pocillopora_meandrina_HIv1___RNAseq.g8511.t1,three_way,40.80866666666667,,,,,,,,,,,,,,,,,
OG_07956,0.2127709210132974,FUN_035500-T1,Peve_00033958,Pocillopora_meandrina_HIv1___RNAseq.g26993.t1,three_way,59.97516666666667,FUN_035500-T1,Q5R2J4,,,,,34.4,430.0,2.7999999999999997e-68,261.2,sp|Q5R2J4|APCD1_PELSI Protein APCDD1 OS=Pelodiscus sinensis OX=13735 GN=APCDD1 PE=2 SV=1,,,,,,
OG_07911,0.2124804691115272,FUN_035369-T1,Peve_00016219,Pocillopora_meandrina_HIv1___TS.g3559.t1,three_way,73.006,FUN_035369-T1,Q5ZIJ9,,,,,36.0,100.0,7e-11,70.1,sp|Q5ZIJ9|MIB2_CHICK E3 ubiquitin-protein ligase MIB2 OS=Gallus gallus OX=9031 GN=MIB2 PE=2 SV=1,,,,,,
OG_07360,0.2123925908185296,FUN_033771-T1,Peve_00006491,Pocillopora_meandrina_HIv1___RNAseq.g26660.t1,three_way,47.66133333333333,FUN_033771-T1,Q7JQD3,GELS1_LUMTE,,Gelsolin-like protein 1 (Actin-modulator) (EWAM) (EWAM-P1),Lumbricus terrestris (Common earthworm),34.7,340.0,7.799999999999999e-49,196.1,sp|Q7JQD3|GELS1_LUMTE Gelsolin-like protein 1 OS=Lumbricus terrestris OX=6398 GN=AM PE=1 SV=1,GO:0003779; GO:0005509; GO:0005737; GO:0015629; GO:0030041; GO:0030043; GO:0045010; GO:0051014; GO:0051015; GO:0051693,actin filament capping [GO:0051693]; actin filament fragmentation [GO:0030043]; actin filament polymerization [GO:0030041]; actin filament severing [GO:0051014]; actin nucleation [GO:0045010],actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737],actin binding [GO:0003779]; actin filament binding [GO:0051015]; calcium ion binding [GO:0005509],GO:0005856; GO:0008092; GO:0043226; GO:0065003,cytoskeleton; cytoskeletal protein binding; organelle; protein-containing complex assembly
